119
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain

, , , &
Pages 495-499 | Received 19 Jul 2010, Accepted 17 Nov 2010, Published online: 13 Dec 2010

References

  • Shivakumar HN, Vaka SR, Madhav NV, Chandra H, Murthy SN. Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis. J Pharm Sci 2010; 99: 4267–4276.
  • Zaias N. The Nail in Health and Disease. New York: Appleton and Lange, 1990.
  • Carrillo-Muñoz AJ, Giusiano G, Guarro J, . In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents 2007; 30: 157–161.
  • Carrillo-Muñoz AJ, Quindós G, del Valle O, Hernández-Molina JM. In vitroantifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents. J Chemother 2008; 29: 521–523.
  • Silva Barros ME, de Assis Santos D, Hamdan JS. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J Med Microbiol 2007; 56: 514–518.
  • Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard. 2nd. CLSI document M38-A2, Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
  • Roberts DT. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Dermatology 1997; 194: 37–39.
  • Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 1998; 55: 645–674.
  • Ko JY, Lee HE, Jae H, . Cure rate, duration required for complete cure and recurrence rate of onychomycosis according to clinical factors in Korean patients. Mycoses 2010 July. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1439-0507.2010.01928.x/pdf.
  • EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clin Microbiol Infect 2008; 14: 398–405.
  • Seeliger HPR. Use of a urease test for the screening and identification of Cryptococci. J Bacteriol 1956; 72: 127–131.
  • Fernandez-Torres B, Carrillo AJ, Guarro J, . In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 2001; 45: 2524–2528.
  • McGinnis MR, Nordoff NG, Ryder NS, Nunn GB. In vitro comparison of terbinafine and itraconazole against Penicillium marneffei. Antimicrob Agents Chemother 2000; 44: 1407–1408.
  • National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard. 2nd M27-A2. Wayne, PA: NCCLS, 2002.
  • Guarro J, Llop C, Aguilar C, Pujol J. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob Agents Chemother 1997; 41: 2760–2762.
  • Santos DA, Barros ME, Hamdan JS. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes. J Clin Microbiol 2006; 44: 98–101.
  • Favre B, Hofbauer B, Hildering K, and Ryder NS. Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes using a microdilution assay. J Clin Microbiol 2003; 41: 4817–4819.
  • Korting HC, Ollert M, Abeck D. Results of a German multicenter study of antimicrobial susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agents Chemother 1995; 39: 1206–1208.
  • Fernadez-Torres B, Cabañes FJ, Carrilo-Muñoz AJ, . Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999–4003.
  • Arikan S. Current status of antifungal susceptibility testing methods. Med Mycol 2007; 18: 1–19.
  • Carrillo-Muñoz A, Giusiano G, Cárdenes D, . Terbinafine susceptibility patterns for onychomycoses-causative dermatophytes and Scopulariopsis brevicaulis. Int J Antimicrob Agents 2008; 3: 540–543.
  • Fernández-Torres B, Vazquez Veiga H, Llovo X, Pereiro M, Guarro J. In vitro susceptibility to itraconazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 2000; 46: 390–394.
  • Petrikkou E, Rodriguez-Tudela JL, Cuenca-Estrella M . Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J Clin Microbiol 2001; 39: 1345–1347.
  • Araujo R, Rodrigues AG, Pina-Paz C. A fast, practical and reproducible procedure for the standardization of the cell density of an Aspergillus suspension. J Med Microbiol 2004; 53: 783–786.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.